APA (7th ed.) Citation

CL, A., N, B., J, H., L, V., S, D., E, A., . . . M, C. (2014). A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events. Breast cancer research and treatment, 144(3), 615. https://doi.org/10.1007/s10549-014-2906-x

Chicago Style (17th ed.) Citation

CL, Addison, et al. "A Phase II, Multicentre Trial Evaluating the Efficacy of De-escalated Bisphosphonate Therapy in Metastatic Breast Cancer Patients at Low-risk of Skeletal-related Events." Breast Cancer Research and Treatment 144, no. 3 (2014): 615. https://doi.org/10.1007/s10549-014-2906-x.

MLA (9th ed.) Citation

CL, Addison, et al. "A Phase II, Multicentre Trial Evaluating the Efficacy of De-escalated Bisphosphonate Therapy in Metastatic Breast Cancer Patients at Low-risk of Skeletal-related Events." Breast Cancer Research and Treatment, vol. 144, no. 3, 2014, p. 615, https://doi.org/10.1007/s10549-014-2906-x.